Pharma giant Eli Lilly boosts India manufacturing with $1B investment
**Pharma Giant Eli Lilly Boosts India Manufacturing with $1B Investment**
*By Mudit Dube | October 6, 2025, 2:13 PM*
Global pharmaceutical leader Eli Lilly has announced plans to invest over $1 billion in India to strengthen the country’s manufacturing and supply capabilities through local drug manufacturers. This significant move aligns with Eli Lilly’s global expansion strategy and its focus on leveraging India’s skilled workforce.
### Strategic Collaboration to Enhance Drug Availability
Eli Lilly’s investment aims to enhance the availability of several key drugs, including treatments for obesity, diabetes, Alzheimer’s disease, cancer, and autoimmune disorders. Patrik Jonsson, the company’s president of international operations, emphasized that Eli Lilly is making major investments to boost manufacturing and medicine supply capacity worldwide. He added that India is a vital hub for building capabilities within their global network.
### Current Manufacturing Approach and New Plans
At present, Eli Lilly relies on contract manufacturers in India, despite launching its blockbuster weight-loss drug Mounjaro in the country earlier this year. The pharmaceutical giant does not yet have its own manufacturing facilities in India but is collaborating with contract manufacturers to expand production capacity. Specific details of these collaborations have not been disclosed.
### Market Context and US Expansion
Eli Lilly’s investment in India comes amid increasing efforts by global drugmakers to bolster their manufacturing presence in the United States, following the Trump administration’s imposition of a 100% tariff on imported branded and patented drugs starting October 1.
Recently, Eli Lilly revealed a $5 billion investment in a new manufacturing facility in Virginia, part of its broader $27 billion expansion plan to build four new US plants over the next five years.
### New Manufacturing and Quality Facility in Hyderabad
As part of its India expansion, Eli Lilly is setting up a manufacturing and quality control facility in Hyderabad. This new hub will oversee the company’s contract manufacturing network across India and offer advanced technical capabilities. Recruitment has already begun, with plans to hire engineers, chemists, analytical scientists, and quality control and assurance experts.
—
Eli Lilly’s continued investment underscores the importance of India in its global manufacturing strategy and highlights the company’s commitment to increasing access to vital medicines worldwide.
https://www.newsbytesapp.com/news/business/eli-lilly-to-invest-1b-in-india-to-boost-manufacturing/story
You may also like
相关资源
You may be interested
The New York Times
- From the Shadows to Power: How the Hindu Right Reshaped India 2025 年 12 月 26 日 Mujib Mashal, Hari Kumar and Atul Loke
- This May Be Our Last Chance to Get It Right in Venezuela 2025 年 12 月 26 日 Jimmy Story
- What to Know About U.S. Military Action in Nigeria 2025 年 12 月 26 日 The New York Times
- Myanmar’s Health Crisis Spills Over Borders 2025 年 12 月 26 日 Verena Hölzl and Lauren DeCicca
- 5 Key Moments in the Rise of India’s Hindu-First Powerhouse 2025 年 12 月 26 日 Mujib Mashal and Hari Kumar
- What to Know About ISIS Terror Attacks 2025 年 12 月 26 日 Eve Sampson
- Death Toll in UPS Plane Crash Rises to 15 2025 年 12 月 26 日 Francesca Regalado
- California Prepares for More Rain After a Soggy Christmas 2025 年 12 月 26 日 Soumya Karlamangla and Alexander Nazaryan
- U.S. Strikes ISIS in Nigeria After Trump Warned of Attacks on Christians 2025 年 12 月 26 日 Helene Cooper, Saikou Jammeh and Eric Schmitt
- Trump Administration Emphasizes Religion in Official Christmas Messages 2025 年 12 月 26 日 Ashley Ahn
Leave a Reply